Corporate News – Redcare

About us Newsroom

Careers Investor Relations

Loading...

Corporate News

Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing based on very convincing e-Rx metrics.

Redcare Pharmacy achieves rapid increase of Rx sales in Germany, continues its strong double-digit overall growth rate and closes Q2 with a solid 2.7% margin.

Strong acceleration of e-Rx sales in Germany for Redcare Pharmacy, from 7% growth in Q1 to 37% in Q2.

Redcare Pharmacy's eHealth-CardLink solution has just been launched: the convenient way to redeem e-prescriptions from anywhere.

Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin. Also in Q1, after many years, breakthrough in online e-Rx in Germany.

Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.

Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board.

Strong start of the year for Redcare Pharmacy, double-digit sales growth continues.

Successful completion of a record year for Redcare Pharmacy: growth 49%, adj. EBITDA margin up 3.7pp to 3%; guidance achieved in all its elements.

Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO).

Another successful fast-growth quarter for Redcare Pharmacy, completing full year 2023 at the very upper end of its guidance.

Show More

Show Less

Redcare Pharmacy: continued very fast growth combined with major margin lift; adj. EBITDA 3.2% in Q3, vs. 0.4% last year.

Redcare Pharmacy continues to successfully grow fast in all its markets.

Redcare Pharmacy Q2 2023: While fast sales growth continues unabated at 46%, adj. EBITDA margin improved 5.3pp year over year to 3.2%. Company raises full-year guidance.

Very successful quarter for Redcare Pharmacy N.V. with a further acceleration in sales growth.

Welcome, Redcare Pharmacy: Official ticker-symbol change on the Frankfurt Stock Exchange and the new corporate site launch today.

SHOP APOTHEKE EUROPE PROMOTED TO THE MDAX.

Joint Venture Approved: SHOP APOTHEKE EUROPE and Galenica Create the Leading Online Pharmacy in Switzerland.

SHOP APOTHEKE EUROPE: STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE.

Successful Outcome for SHOP APOTHEKE EUROPE's Annual General Meeting 2023: Approval of New CEO and Change of Corporate Name.

SHOP APOTHEKE EUROPE: VERY STRONG START TO YEAR, FASTEST GROWTH SINCE EARLY 2021.

SHOP APOTHEKE EUROPE and GALENICA enter into a strategic partnership and jointly establish the leading online pharmacy in Switzerland.

SHOP APOTHEKE EUROPE N.V. PUBLISHES CONVOCATION FOR ANNUAL GENERAL MEETING OF SHAREHOLDERS 2023

SHOP APOTHEKE EUROPE TO APPOINT OLAF HEINRICH AS NEW CEO.

SHOP APOTHEKE EUROPE 2022: RECORD SALES OF EUR 1.2 BILLION AND SIGNIFICANTLY IMPROVED MARGINS IN THE SECOND HALF OF THE YEAR.

CEO Stefan Feltens to Retire from SHOP APOTHEKE EUROPE.

SHOP APOTHEKE EUROPE: STRONG ORGANIC GROWTH CONTINUES.

Show More

Show Less

At the VISION 2045 Summit alongside the COP 27: CEO Stefan Feltens presents SHOP APOTHEKE EUROPE’s NET ZERO 2040 Strategy in Sharm El Sheikh.

SHOP APOTHEKE EUROPE: SOLID AND SUCCESSFUL QUARTER, FULLY IN LINE WITH GUIDANCE. BETTER MARGINS AND CONTINUED MARKET SHARE GAINS.

SHOP APOTHEKE EUROPE: STRONG OPERATIONAL PERFORMANCE, GROWING FAST AND IMPROVING THE BOTTOM LINE.

SHOP APOTHEKE EUROPE presents its NET ZERO Strategy 2040 at this year's Retail Media Summit.

SHOP APOTHEKE EUROPE: New Italian distribution centre fully operational.

SHOP APOTHEKE EUROPE READY FOR THE NEXT PHASE OF E-PRESCRIPTIONS IN GERMANY.

SHOP APOTHEKE EUROPE CONFIRMS FULL-YEAR TOP AND BOTTOM LINE GUIDANCE AFTER STRONG H1 SALES PERFORMANCE.

SHOP APOTHEKE EUROPE ACCELERATES TOTAL SALES GROWTH TO 15% – FULL YEAR GUIDANCE RE-CONFIRMED.

SHOP APOTHEKE EUROPE Launches second Marketplace – after Germany, now Austria.

SHOP APOTHEKE EUROPE: SOLID START TO THE YEAR CONFIRMS GUIDANCE FOR 2022.

SHOP APOTHEKE EUROPE CONTINUES TO SHAPE THE FUTURE OF ONLINE PHARMACIES. ACQUISITION OF 'FIRST A', A PIONEERING QUICK-COMMERCE PLAYER IN THE GERMAN PHARMACY MARKET.

SHOP APOTHEKE EUROPE: NON-PRESCRIPTION SALES CONTINUE TO GROW BY DOUBLE-DIGITS IN LINE WITH GUIDANCE.

SHOP APOTHEKE EUROPE: E-PHARMACY NUMBER 1 IN GERMANY AND AUSTRIA.

SHOP APOTHEKE EUROPE N.V. PUBLISHES AGENDA ANNUAL GENERAL MEETING OF SHAREHOLDERS 2022.

SHOP APOTHEKE EUROPE 2021: Exceeding One Billion Euro Sales Mark with Record Number of Active Customers and Significant Market Share Gains in Non-Rx.

SHOP APOTHEKE EUROPE PROPOSES JASKA DE BAKKER FOR ELECTION TO ITS SUPERVISORY BOARD.

SHOP APOTHEKE EUROPE upgraded to AA rating by MSCI.

SHOP APOTHEKE EUROPE Expands in Italy with New Logistics Centre.

SHOP APOTHEKE EUROPE: STRONG ACCELERATION OF SALES AND CUSTOMER GROWTH IN Q4.

Show More

Show Less

MedApp Starts Co-operation with Dutch Health Insurer VGZ.

SHOP APOTHEKE EUROPE Launches its Own Marketplace.

SHOP APOTHEKE EUROPE Cracks the One Billion Euro Turnover Mark.

SHOP APOTHEKE EUROPE: 9M Growth of 9.8% and Adjusted EBITDA Margin +0.6%.

SHOP APOTHEKE EUROPE: PROCESSED THE FIRST E-PRESCRIPTION.

SHOP APOTHEKE EUROPE: Strong growth of everything-but-Rx.

SHOP APOTHEKE EUROPE: Move to Next Generation Logistics Centre Completed.

SHOP APOTHEKE EUROPE: Sales Growth 15% in H1. All Set for E-Prescriptions.

SHOP APOTHEKE EUROPE: Growth in Q2 temporarily decelerated to 7.3%. Preliminary sales grew by 14.9% during the first six months of 2021.

SHOP APOTHEKE EUROPE: Strong Start into 2021 with 22.4% Sales Growth and 2.0% adj. EBITDA Margin.

SHOP APOTHEKE EUROPE N.V.: Annual General Meeting approves all items on the agenda and appoints Henriette Peucker as a member of the Supervisory Board.

SHOP APOTHEKE EUROPE PARTICIPATES IN CAMPAIGN 'TIME FOR CLIMATE ACTION' AS PART OF EARTH DAY 2021.

SHOP APOTHEKE EUROPE: Fast growth continues, Q1 revenues up 22.5%.

SHOP APOTHEKE EUROPE: Acquisition of MedApp to Expand in Rx and Medication Management in the Netherlands.

SHOP APOTHEKE EUROPE proposes Henriette Peucker for election to its Supervisory Board; Björn Söder to become Chairman of Supervisory Board.

SHOP APOTHEKE EUROPE N.V. PUBLISHES AGENDA ANNUAL GENERAL MEETING OF SHAREHOLDERS 2021.

SHOP APOTHEKE EUROPE Exceeds Repeatedly Raised Sales and Earnings Guidance for 2020 after Strong Fourth Quarter.

SHOP APOTHEKE EUROPE announces result of convertible bond placement.

SHOP APOTHEKE EUROPE continues its fast growth: Q4 sales up 38%, full year 2020 growth 38.1%.

SHOP APOTHEKE EUROPE: Expansion of Digital Medication Management Capabilities Through Acquisition of SMARTPATIENT.

Show More

Show Less

SHOP APOTHEKE EUROPE continues its dynamic growth course and again raises its 2020 guidance.

SHOP APOTHEKE EUROPE grows by 39.7% in Q3.

SHOP APOTHEKE EUROPE promoted to MDAX.

SHOP APOTHEKE EUROPE: 42% growth and significantly improved bottom line in Q2; adjusted Q2 EBITDA margin 2.7%.

SHOP APOTHEKE EUROPE: GROWTH ACCELERATES FURTHER TO 42% IN Q2. H1 GROWTH IS 37% NOW.

SHOP APOTHEKE EUROPE achieves positive EBITDA ahead of schedule and increases sales by 33% in Q1.

SHOP APOTHEKE EUROPE N.V.: Annual General Meeting approves all items on the agenda.

SHOP APOTHEKE EUROPE: Growth accelerated to 33% in Q1, revenues up to EUR 232 million.

SHOP APOTHEKE EUROPE COMMITS TO UN GLOBAL COMPACT STANDARDS.

SHOP APOTHEKE EUROPE N.V. PUBLISHES AGENDA ANNUAL GENERAL MEETING OF SHAREHOLDERS 2020

SHOP APOTHEKE EUROPE DELIVERED HIGH GROWTH AND BETTER MARGINS IN 2019, ENDING THE YEAR WITH A STRONG Q4.

SHOP APOTHEKE EUROPE continues to grow dynamically; 2019 revenues increase to over EUR 700 million.

Jasper Eenhorst named new CFO of SHOP APOTHEKE EUROPE.

SHOP APOTHEKE EUROPE increases Group revenues by more than 30% to EUR 509 million during the first nine months of 2019.

SHOP APOTHEKE EUROPE: Group revenues rise significantly by +31% to around EUR 509 million during the first nine months of 2019.

SHOP APOTHEKE EUROPE continues successful growth course; revenues rise by 32% to EUR 338 million during first half of 2019.

SHOP APOTHEKE EUROPE N.V. continues its growth course during the first half of 2019; consolidated revenues increase by 32% to EUR 338 million.

Groundbreaking for new logistics centre: SHOP APOTHEKE EUROPE presents the online pharmacy of the future.

SHOP APOTHEKE EUROPE reports sales growth of 33% in the first quarter of 2019.

SHOP APOTHEKE EUROPE N.V.: General Meeting confirms company's European growth strategy.

SHOP APOTHEKE EUROPE announces result of capital increase and tap of convertible bond

SHOP APOTHEKE EUROPE N.V.: Invitation Conference Call

SHOP APOTHEKE EUROPE starts the year strongly: Consolidated revenues increase by 33% to over EUR 174 million during the first quarter.

SHOP APOTHEKE EUROPE N.V. PUBLISHES AGENDA ANNUAL GENERAL MEETING OF SHAREHOLDERS 2019

SHOP APOTHEKE EUROPE N.V. increases revenues by over 90% to EUR 540 million in 2018

SHOP APOTHEKE EUROPE reaches 2018 growth target; consolidated revenues of EUR 540 million.

SHOP APOTHEKE EUROPE increases consolidated revenues by +103% to over EUR 388 million for the first nine months of 2018.

SHOP APOTHEKE EUROPE N.V.: SHOP APOTHEKE EUROPE: Consolidated revenues grow significantly by +104% to ca. EUR 389 million during the first nine months of 2018.

WEBSHOP AWARDS Germany 2018-2019: SHOP APOTHEKE named 'Online Retailer of the Year'.

SHOP APOTHEKE EUROPE N.V. strengthens management team with Stefan Feltens, former CFO of Teva Global Operations, and confirms mid-term annual revenue target of 1 bn EUR.

SHOP APOTHEKE EUROPE to be included in SDAX select index.

Half-year revenues more than doubled: SHOP APOTHEKE EUROPE continues accelerated growth course.

SHOP APOTHEKE EUROPE N.V. takes over specialist for functional nutrition products nu3 GmbH, Berlin.

SHOP APOTHEKE EUROPE continues its accelerated growth course. Consolidated revenues more than doubled to EUR 257 million during the first half of 2018.

SHOP APOTHEKE EUROPE posts strong growth during first quarter of 2018.

SHOP APOTHEKE EUROPE N.V.: Annual General Meeting welcomes European growth strategy.

Preliminary sales: SHOP APOTHEKE EUROPE achieves an excellent start into the financial year 2018 with a 105 % revenue increase in Q1.

SHOP APOTHEKE EUROPE N.V. places EUR 75m convertible bonds to support external growth.

SHOP APOTHEKE EUROPE N.V. PUBLISHES AGM CONVOCATION AND AGENDA.

SHOP APOTHEKE EUROPE increases revenues by 60% in 2017; growth projected to further accelerate in 2018 with positive Group-level EBITDA expected.

SHOP APOTHEKE EUROPE N.V.: German coalition parties intend to plead for ban of Rx mail order.

SHOP APOTHEKE EUROPE: Pace of growth once again increased in 2017.

SHOP APOTHEKE EUROPE increases consolidated revenues by 53% and confirms raised guidance.

SHOP APOTHEKE EUROPE completes capital increase against contribution in kind and acquires Europa Apotheek Venlo.

SHOP APOTHEKE EUROPE N.V.: General Meeting gives unanimous approval to takeover of Europa Apotheek Venlo

SHOP APOTHEKE EUROPE N.V.: Consolidated revenues grow by +53% to over EUR 191 m in the first nine months of 2017.

SHOP APOTHEKE EUROPE N.V. PUBLISHES EGM CONVOCATION AND AGENDA.

SHOP APOTHEKE EUROPE to strengthen European market leadership through the acquisition of mail-order pharmacy Europa Apotheek.

SHOP APOTHEKE EUROPE improves profitability in first half of 2017 and continues accelerated growth course.

SHOP APOTHEKE EUROPE: Accelerated growth continues with revenue increase of +54% to more than EUR 126 million in 1st HY 2017.

SHOP APOTHEKE EUROPE N.V.: Strong sales growth also in May reaffirms guidance.

SHOP APOTHEKE EUROPE N.V.: BEST OF ALL ONLINE PHARMACIES.

SHOP APOTHEKE EUROPE N.V.: shareholders' meeting: Company accelerates European growth

SHOP APOTHEKE EUROPE optimistic after strong first quarter: Growth accelerated, gross margin increased.

Preliminary results: SHOP APOTHEKE EUROPE accelerates international expansion and further speeds up growth rate.

SHOP APOTHEKE EUROPE N.V. PUBLISHES AGM CONVOCATION AND AGENDA.

SHOP APOTHEKE EUROPE grows more than twice as fast as the overall Continental European market in 2016. Accelerated growth projected for 2017 as well.

SHOP APOTHEKE EUROPE continues dynamic growth course in 2016.

SHOP APOTHEKE EUROPE with strong revenue growth in the first 9 months of 2016.

SHOP APOTHEKE EUROPE N.V.: Exercise of greenshoe option and early termination of stabilisation period

SHOP APOTHEKE EUROPE sets IPO price at EUR 28.00 per share

SHOP APOTHEKE EUROPE N.V.: Securities prospectus approved

SHOP APOTHEKE EUROPE announces price range for IPO

SHOP APOTHEKE EUROPE prepares for Initial Public Offering

Show More

Show Less